In Alzheimer’s, There’s A Lot Of Room Under The Radar
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
At the Alzheimer’s Association International Conference in July, a number of companies reported findings alongside headliners Lilly, Merck and AstraZeneca.